Francesca Levi-Schaffer

Francesca Levi-Schaffer holds the Isaac and Myrna Kaye Chair in Immunopharmacology at the Hebrew University of Jerusalem. She leads research on mast cells and eosinophils as effector cells in allergic diseases at the Institute for Drug Research.

Key research areas:

• Immunopharmacological modulation of allergic diseases
• Bispecific antibody development
• Mast cell-eosinophil interactions in inflammation
• Novel treatments for asthma and atopic dermatitis
• Non-IgE mediated mast cell activation pathways

Patent portfolio includes innovations in:

• Bi-specific complexes for allergic reactions (2005)
• CD48 targeting for anti-asthmatic therapy (2006)
• Mast cell pathology treatments (2011)